Chris is Professor of Pharmaceutics at the Monash Institute of Pharmaceutical Sciences and Director, Monash Institute of Pharmaceutical Sciences. Chris’ group works to address the poor oral absorption of drugs with intrinsically low water solubility, and to develop delivery systems to enhance the activity and reduce the toxicity of anti-cancer agents.
Professor Porter is currently actively investigating within the following Signature Projects:
|A new in vitro lipid digestion – In vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations||2016||Crum, M. F.; Trevaskis, N. L.; Williams, H. D.; Pouton, C. W.; Porter, C. J. H.|
|Hyaluronic Acid Molecular Weight Determines Lung Clearance and Biodistribution after Instillation.||2016||Kuehl, C.; Zhang, T.; Kaminskas, L. M.; Porter, C. J.; Davies, N. M.; Forrest, L.; Berkland, C.|
|Passive tumour targeting and extravasation of cylindrical polymer brushes in mouse xenografts||2016||Müllner, M.; Mehta, D.; Nowell, C.J.; Porter, C.J.|
|Tools for early prediction of drug loading in lipid-based formulations||2016||Alskär, L. C.; Porter, C. J. H.; Bergström, C. A. S.|
|Understanding the Challenge of Beyond-Rule-of-5 Compounds||2016||Bergström, C.; Porter, C.|